This was a controlled, parallel-group, single-blinded, randomized pilot study carried out from March 2024 to June 2024, with chronic pain patients with the aim to evaluate the prospect of a larger ...

The U.S. Food and Drug Administration (FDA) is moving to speed drug development and review by launching real-time clinical trials. The move could soon mean more options for patients who need ...

Geriatrics and Aging. 2005;8(6):43-45. Is the treatment still indicated or has the diagnosis been refuted? For example, a putative diagnosis of angina may have subsequently been disproved. Treatments ...

Healthcare continues to suffer from a one-size-fits-all, trial-and-error model. Precision medicine seeks individualized care but requires clinical trial cohorts that ...

Phase Ib Study of BI 836880 (VEGF/Ang2 nanobody) in Combination With Ezabenlimab (anti–PD-1 antibody) in Patients With Advanced or Metastatic Solid Tumors From December 2022 to January 2025, one MRT ...

The agency announced that it has completed the first tests of a system that allows FDA scientists to see safety and effectiveness data from patients as it is collected, turning the traditional process ...